Search Results
PLEASE NOTE: the default search returns results for drug names, but you can search using other keywords.
If your search returns no results, try one of the tabs to search in tables, guidelines, drug news or patient resources. Also check results for indications, contraindications, warnings, interactions and side effects.
Tyrosine kinase inhibitor for kidney cancer
Votrient (pazopanib) is indicated for the treatment of advanced renal cell carcinoma (RCC), both as first-line treatment and following previous cytokine therapy.
Diovan for paediatric use
Diovan (valsartan) 40mg and 320mg tablets have had their licences extended to include treatment of hypertension in children and adolescents, 6 to 18 years of age. Use of Diovan for this indicatio...
MHRA restricts quinine use
The MHRA has issued guidance that quinine should not be considered a routine treatment for nocturnal leg cramps. Although generally well tolerated, its efficacy is modest and a small number of de...
New indication for Tyverb
Tyverb (lapatinib) has had its licence extended to include use in combination with an aromatase inhibitor (AI), for the first-line treatment of post-menopausal women with hormone receptor (HR)-posi...
Deleted products 2010
The following products have been discontinued from the UK market this year. The list below states the month they were withdrawn from MIMS.
First antibody treatment for osteoporosis
Prolia (denosumab) is indicated for the treatment of osteoporosis in postmenopausal women at increased risk of fractures, and for bone loss associated with hormone ablation in men with prostate cancer...
Arzerra: new leukaemia antibody
GlaxoSmithKline has launched a new biological treatment for chronic lymphocytic leukaemia (CLL).
Celecoxib for familial adenomatous polyposis
Onsenal is a new preparation of the COX-2 inhibitor celecoxib, indicated for use in familial adenomatous polyposis (FAP). Patients with this condition develop large numbers of intestinal polyps tha...
New LABA inhaler for COPD
Novartis has launched Onbrez Breezhaler (indacaterol), a dry-powder inhaler containing a novel long-acting beta agonist for COPD.
Pentasa Sachets licensed for paediatric use
Pentasa Sachets (mesalazine) are now licensed for use in children with mild to moderate ulcerative colitis, from the age of 6 years. As a general rule, half the adult dose may be given to childre...
Somatropin NICE approval extended
Somatropin (synthetic human growth hormone) can now be prescribed on the NHS for two additional paediatric indications. In addition to children with growth failure associated with growth hormone ...
Epoetin theta launched
Eporatio (epoetin theta) has been launched by Ratiopharm for the treatment of symptomatic anaemia in adults with chronic renal failure and in those receiving chemotherapy for non-myeloid malignanci...
Glucosamine in sachets
Glusartel is a powdered glucosamine product for oral solution. Like other licensed glucosamine formulations, the once-daily 1500mg sachets are indicated for mild to moderate osteoarthritis of the k...
Crestor approved for paediatric and prophylactic use
Crestor (rosuvastatin) has been approved for two additional indications: heterozygous familial hypercholesterolaemia in children aged 10 17 years and primary prevention of major cardiovascular even...
New combination tablet for type II diabetes
Janumet (sitagliptin/metformin) is a new fixed-dose combination treatment for patients with inadequately controlled type II diabetes.
New Ebixa packaging for easier administration
Ebixa (memantine) solution is now presented with a dispensing pump, allowing doses to be easily measured and making dosing simpler for patients. The pump dispenses 5mg per 0.5ml per actuation. Th...
Zocor for heterozygous familial hypercholesterolaemia
The licence for Zocor (simvastatin) has been extended to include use in children and adolescents, 10-17 years of age, with heterozygous familial hypercholesterolaemia. Boys should be Tanner stage ...
Dolenio for osteoarthritis
Dolenio is a new glucosamine product licensed for the symptomatic treatment of mild to moderate osteoarthritis of the knee. Dolenio is a once daily tablet formulation of glucosamine sulphate. Tre...
New fertility drug
Elonva (corifollitropin alfa) is a new sustained follicle stimulant for women participating in assisted reproductive technology programmes.
Oral therapy for chronic immune thrombocytopenic purpura
Revolade (eltrombopag) is the first oral treatment option for chronic immune thrombocytopenic purpura to be launched in the UK.
MIMs Drug Search
Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.
